BIOMAT Database Logo BIOMAT Database Logo

A novel missense mutation in the type II 3 beta-hydroxysteroid dehydrogenase gene in a family with classical salt-wasting congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency. 1995

N Katsumata, and A Tanae, and T Yasunaga, and R Horikawa, and T Tanaka, and I Hibi
Department of Endocrinology and Metabolism, National Children's Medical Research Center, National Children's Hospital, Tokyo, Japan.

UI MeSH Term Description Entries
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005192 Family Health The health status of the family as a unit including the impact of the health of one member of the family on the family as a unit and on individual family members; also, the impact of family organization or disorganization on the health status of its members. Health, Family
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000312 Adrenal Hyperplasia, Congenital A group of inherited disorders of the ADRENAL GLANDS, caused by enzyme defects in the synthesis of cortisol (HYDROCORTISONE) and/or ALDOSTERONE leading to accumulation of precursors for ANDROGENS. Depending on the hormone imbalance, congenital adrenal hyperplasia can be classified as salt-wasting, hypertensive, virilizing, or feminizing. Defects in STEROID 21-HYDROXYLASE; STEROID 11-BETA-HYDROXYLASE; STEROID 17-ALPHA-HYDROXYLASE; 3-beta-hydroxysteroid dehydrogenase (3-HYDROXYSTEROID DEHYDROGENASES); TESTOSTERONE 5-ALPHA-REDUCTASE; or steroidogenic acute regulatory protein; among others, underlie these disorders. Congenital Adrenal Hyperplasia,Hyperplasia, Congenital Adrenal,Adrenal Hyperplasias, Congenital,Congenital Adrenal Hyperplasias,Hyperplasias, Congenital Adrenal
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

N Katsumata, and A Tanae, and T Yasunaga, and R Horikawa, and T Tanaka, and I Hibi
Mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene in a patient with classic salt-wasting 3 beta-hydroxysteroid dehydrogenase deficiency congenital adrenal hyperplasia.
November 1993, Pediatric research,
N Katsumata, and A Tanae, and T Yasunaga, and R Horikawa, and T Tanaka, and I Hibi
Delayed diagnosis of congenital adrenal hyperplasia with salt wasting due to type II 3beta-hydroxysteroid dehydrogenase deficiency.
April 2005, The Journal of clinical endocrinology and metabolism,
N Katsumata, and A Tanae, and T Yasunaga, and R Horikawa, and T Tanaka, and I Hibi
A new compound heterozygous frameshift mutation in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene causes salt-wasting 3 beta-HSD deficiency congenital adrenal hyperplasia.
January 1996, The Journal of clinical endocrinology and metabolism,
N Katsumata, and A Tanae, and T Yasunaga, and R Horikawa, and T Tanaka, and I Hibi
Congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency.
April 1996, European journal of pediatrics,
N Katsumata, and A Tanae, and T Yasunaga, and R Horikawa, and T Tanaka, and I Hibi
Congenital adrenal hyperplasia due to point mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene.
July 1992, Nature genetics,
N Katsumata, and A Tanae, and T Yasunaga, and R Horikawa, and T Tanaka, and I Hibi
Molecular basis of congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency.
May 1993, Molecular endocrinology (Baltimore, Md.),
N Katsumata, and A Tanae, and T Yasunaga, and R Horikawa, and T Tanaka, and I Hibi
Congenital adrenal hyperplasia owing to 3 beta-hydroxysteroid dehydrogenase deficiency.
March 2001, Endocrinology and metabolism clinics of North America,
N Katsumata, and A Tanae, and T Yasunaga, and R Horikawa, and T Tanaka, and I Hibi
[Congenital adrenal hyperplasia due to blockade of 3-beta-hydroxysteroid dehydrogenase].
January 1979, Archives francaises de pediatrie,
N Katsumata, and A Tanae, and T Yasunaga, and R Horikawa, and T Tanaka, and I Hibi
Congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase type II deficiency in 4 Saudi children. Long term follow up.
September 2004, Saudi medical journal,
N Katsumata, and A Tanae, and T Yasunaga, and R Horikawa, and T Tanaka, and I Hibi
Carboxyl-terminal mutations in 3beta-hydroxysteroid dehydrogenase type II cause severe salt-wasting congenital adrenal hyperplasia.
April 2008, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!